Twists and turns in protein folding  by unknown
Protein folding is fast becoming the
bottleneck for researchers who want
to make the best possible use of the
bounty of genome information that is
becoming available at an ever
increasing pace. If only one could
feed each new sequence into a
computer and let it wriggle the
polypeptide chain about in silico, to
see what three-dimensional structure
it ends up with, the proteins encoded
by the genomes already sequenced
would soon become an open book.
But sadly, although protein design
has made spectacular progress during
the 1990s, allowing researchers to
‘write’ protein sequence that will
fold up to a desired structure,
attempts at learning how to read the
‘second half of the genetic code’
have lagged behind. 
Part of the problem is in the
sheer computational complexity of
protein folding. Molecular modellers
today can simulate movements and
conformational changes of protein
chains over a number of steps
typically spaced in femtoseconds
(10–15 sec). But even using weeks on
a typical workstation, these small
steps will only add up to
nanoseconds in real time. Real
proteins, in contrast, require tens of
thousands to tens of billions of times
longer than this to fold. Thus, a
massive increase in computer power
would be necessary if folding in silico
is to make a useful contribution to
understanding folding mechanisms
and ultimately being able to predict
folds from sequences. Two separate
projects have taken up this challenge
in very different ways. IBM are
building a gigantic supercomputer,
while a group at Stanford University
have developed algorithms to cut the
problem into small chunks that can
be farmed out to large numbers of
ordinary home PCs. 
Protein folding is fast becoming a
bottleneck for researchers
The $100 million research project
which IBM announced in December
1999 was originally driven by the
desire to build the fastest possible
computer. Looking for a real life
problem that could justify this
ambition, the IBM people came
across the folding simulation
problem and hitched it to their cart.
Dennis Newns, one of the research
scientists of the project, uses a real
protein example to show up the
limitations of present day
supercomputers: to simulate the
movements of a protein domain,
such as the villin head piece with
only 67 amino acids over a timespan
of one microsecond, he says, a Cray
T3E supercomputer would require
2.5 months. And as most real proteins
fold in seconds rather than
microseconds, simulations of folding
would simply be impossible even
with today’s supercomputers or their
immediate successors. 
Within five years, IBM want to
build a computer which at the
current rate of progress would arrive
in 15 years. Their strategy to achieve
this is called SMASH: simple, many,
and selfhealing processors. The
machine will contain one million
processors, each working at a speed
of one gigaflop (one billion floating
point operations per second). The
overall design has five levels of
increasing complexity: there are
32 processors on a chip, 64 chips on a
board, eight boards in a tower, and
Blue Gene will consist of 64 such
towers, bringing the total power to
one petaflop, or a million gigaflops.
The self-healing ability is due to the
redundancy of processors and
communications between them.
Should one of the processors fail, it
can be easily bypassed. The overall
performance of Blue Gene will also
be boosted by the fact that the
memory will be located in the
processor chips, and by the
incredible communications
bandwidth of the whole machine.
IBM boast that Blue Gene could
download the entire content of
today’s web in less than a second. 
Opinions are divided as to how
useful the machine will be for folding
studies when it goes live in or around
2005. To arrive at a correct simulation
of the folding process, researchers
will not only need massive computer
power, but also a correct set of
physical parameters (force fields) to
start with. Force fields existing so far
have been useful for some problems,
but not for others. Comparing Blue
Gene to the computer that beat
Kasparov at chess, Oxford
biophysicist Michele Vendruscolo
says: “Unlike Deep Blue, Blue Gene
will not play by the true rules of the
game but only by approximate ones.”
On a more hopeful note, he adds:
“Even if IBM will not be successful
in folding proteins we will learn
more about the principles of
biomolecular behaviour.”
The other problem with the IBM
approach is that, like any computer
you buy in the shop, Blue Gene will
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start ageing as soon as it’s built. The
exponential increase in the
performance of other computers will
not pause while Blue Gene is being
built, so maybe by 2010, a small
network of two dozen commercial
desktops could beat Blue Gene at
the folding game. Newns admits that
the useful lifetime of Blue Gene may
be as short as three years. An
alternative approach that bypasses
this problem and is also a lot cheaper
to put into practice has been
pioneered by the group of Vijay
Pande at Stanford University. 
Following in the footsteps of the
SETI@home project, which farms
out the analysis of cosmic radiowaves
for traces of extraterrestrial
broadcasters to millions of computer
users, Pande developed
‘folding@home’, which uses a similar




download a screensaver which will
run a small part of a folding
simulation whenever their computer
is not used. Pande’s group developed
a new approach to folding simulation,
whereby the calculations can be
separated into chunks corresponding
to the transition from one local
energy minimum to another one.
From each state, there are many
different ways in which a protein can
move about, hence there is a need
for massive parallelism to find out
which of these ways will
productively lead to the next state.
Once the next step has been
achieved on one of the computers
working in parallel, it is again used as
a starting point for renewed parallel
simulation efforts. 
This approach shares the first
problem with Blue Gene: the output
will only be as good as the physical
parameters used for the input. But it
has the advantage that it can grow
and develop with the development
of new commercial computers. So by
2005, the network of users hooked
up to folding@home may have
become nearly as powerful as Blue
Gene, and unlike the latter, it will
continue to grow. 
Some even think that a
combination of the two approaches
may hold the clue to the folding
conundrum. As Kevin Plaxco, who
investigates protein folding at the
University of California at Santa
Barbara, suggests: “Blue Gene’s
one million processors may not
necessarily perform better than one
thousand processors, because the
efficiency of using parallel
computing in molecular dynamics
drops rapidly when each processor
is in charge of fewer than a few
hundred atoms.” But, he says,
“using the folding@home
algorithm to run a thousand
simulations in parallel, each on one
thousand of Blue Gene’s processors,
could solve this problem. The
two approaches could turn out to
be complementary.”
Michael Gross is a science writer based at
the Oxford Centre for Molecular Sciences.
He can be contacted through his web page
at www.michaelgross.co.uk. 
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